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Doxycycline,  an oral  antimicrobial,  does  not  present  a  sustainable analytical  method described in  the literature  using liquid
chromatography. A new and efficient method was developed and validated for the quantification of doxycycline tablets by HPLC-
UV. Its aim is the contribution to the green analytical chemistry since it has low use of organic solvent and low production of
toxic waste. The HPLC-UV method used a mixture of purified water + 0.5 % acetic acid and ethanol (40:60, v/v). The flow rate
was 0.8 mL min-1, C18 Luna column, 20 μL of injected volumes at 275 nm. The samples were prepared in purified water and theL of injected volumes at 275 nm. The samples were prepared in purified water and the
method was linear over the concentration range of 20–200 μL of injected volumes at 275 nm. The samples were prepared in purified water and theg mL-1 (r = 0.9997) with limits of detection and quantification of 1.08
and 3.27 μL of injected volumes at 275 nm. The samples were prepared in purified water and theg mL-1, respectively. The precision of the method showed RSD 0.50 % (intra-assay), 2.35 % (inter-assay) and 1.13 %
(between analysts). The accuracy of the method was determined by standard recovery and it was 99.85 %. The DOX tablets were
subjected to oxidative, acid, basic, neutral and photolytic degradation and it showed be stability indicative. Statistical analysis
provided reliable, safety and reproducible results. The method is considered linear, selective, precise, accurate, robust, indicative
of stability and safe to be used in routine quality control analyzes for determination and quantification of doxycycline in tablets.
The proposed method is an ecologically correct alternative for the evaluation of doxycycline tablets.
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Introduction 
Doxycycline (DOX, Figure 1) is a second generation semi-
synthetic  antibiotic  of  tetracycline  family  (1).  DOX is  an
antibiotic  used  for  treatments  of  diseases  caused  by
anaerobic and aerobic bacteria (2) as well as Gram-negative
and  Gram-positive  bacteria  (3).  DOX  is  preferentially
chosen when compared to the other tetracycline in specific
infections due to the high absorption and its long half-life.
This  allows  a  lower  dosage  frequency  (4)  and  to  have  a
better  clinical  efficacy  in  low  concentrations,  such  as
between  2  or  4  times  the  level  of  minimal  of  inhibition
concentration (MIC) for susceptible microorganisms (5).The
high  performance  liquid  chromatography  (HPLC)  is  an
analytical technique widely used in analytical laboratories of
chemical and pharmaceutical industries for routine analysis
of  quality  control  (6-7). Among  the  techniques  used  in
quality control, HPLC is a technique with major advantages
since  it  provides  faster  analysis,  better  resolution,  greater
sensitivity, detectability and precision (8).
                     
Figure 1. Chemical structure of DOX (CAS 24390-14-5).
High performance liquid chromatography has been used to
determine doxycycline in biological fluids, serum, blood or
urine (9), and mainly in pharmaceutical products as tablets
(10) and capsules (11-12). However, the most methods using
HPLC  to  determine  DOX  use  of  toxic  solvents  as
acetonitrile,  methanol  or  oxalic  acid  (9,  13),  which  when
compounded  compromise  the  health  of  operators,  and  in
addition, if  discarded  incorrectly,  to  the environment  (14-
16).  Therefore,  it  is necessary and important  to use green
analytical  chemistry  in  the  development  of  chemical
techniques and methods that reduce or eliminate the use of
solvents,  reagents  or  the  generation  of  toxic  waste  while
maintaining accuracy, sensitivity and reproducibility of the
analytical  method  for  DOX  quantification  in  tablets  by
HPLC. 
The search for ecologically  sustainable methodologies has
been  important  in  pharmaceutical  industries,  highlighting
trends  in  eliminate  the  mobile  phases  composed  of  toxic
organic solvents. This brings benefits not only for industries,
as well as for operators and the environment (14-16). HPLC
technique  is  expensive  due  to  costs  of  equipment,
accessories, reagents and personnel training (17) and the use
of  anti-toxic  solvents  reduce  once  environmental  impacts
will  reduce  toxic waste,  develop  simpler  methods,  reduce
solvent  elimination,  lower  production  costs,  lower
equipment  risks  and  longer  shelf  life  of  chromatographic
columns  (18).  Besides  that,  ethanol  is  a  biodegradable
solvent, the environmental impacts are minimized and can
be easily replaced and reused because it  is the least  toxic
(19). Currently, the use of water and ethanol as mobile phase
is  already  a  reality;  methods  to  determine  drugs  such  as
sodium  cefepime  hydrochloride  (20),  ceftriaxone  sodium
(21),  cefadroxil  (22),  daptomycin  (23),  ampicillin  (24),
cefazolin  sodium (25)  aztreonam  (26)  and  rifaximin  (27)
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were  developed  and  validated  using  green  analytical
chemistry.
In addition, DOX has highly solubility  in water,  which it
was  possible  to  prepare  the  samples  in  aqueous  medium,
further contributing to green analytical chemistry.
This paper describes the development and validation of high
performance  liquid  chromatographic  technique  for  the
quantification  of  doxycycline  in  tablets  using  no  toxic
solvents, aiming to contribute to green analytical chemistry
and  to  environment  preservation  and  safety  of  operators.
Moreover,  the  method  shows  reliable  results  that  can  be
satisfactorily interpreted.
Experimental
Reagents 
Materials  and  standards  HPLC  grade  ethanol  (Panreac®,
Barcelona,  Spain),  HPLC grade  acetic  acid  (J.T.  Baker®,
Phillipsburg,  NJ)  were  used.  Deionized  Milli  Q  water
(Millipore®, Bedford, MA) was used to prepare the mobile
phase and diluent solutions. DOX standard and tablets were
supplied by União Química Pharmaceutical (Pouso Alegre,
Brazil). 
Equipment 
HPLC analysis was performed on a Waters® HPLC system
equipped  with  a  Waters  1525  binary  gradient
chromatography  pump;  a  Rheodyne  Breeze  7725i  manual
injector  and  a  Waters  2487  ultraviolet-visible  (UV-Vis)
detector.
Chromatographic conditions 
Chromatographic  analysis  was  conducted  at  ambient
temperature on a C18 Luna column (250 mm x 4.6 mm, 5.0
µm  particle  size).  The  mobile  phase  was  a  mixture  of
purified water + 0.5% acetic acid and ethanol in the ratio
40:60 (v/v), and filtering through a 0.45 µm membrane filter.
A stock standard solution equivalent to 200 μL of injected volumes at 275 nm. The samples were prepared in purified water and theg mL -1  DOX
was prepared by dissolving an accurately weighed amount
of pure drug in the diluent solution. The  flow rate was 0.8
mL min-1, at 275 nm and injection volume of 20 µL.
Pharmaceutical preparations
Twenty tablets were accurately weighed, crushed into a fine
powder and mixed using a mortar and pestle. A quantity of
tablet  powder  equivalent  to 80 mg of  DOX was weighed
accurately into a 25 mL calibrated flask; the diluent solution
was  added  and  the  mixture  was  sonicated  for  5  min  to
complete  dissolution  of  the  DOX;  the  mixture  was  then
diluted to the mark with the diluent. A small portion of the
resulting mixture was withdrawn and filtered through a 0.45
µm  filter  to ensure the absence  of particulate matter.  The
filtrate  was  appropriately  diluted  with  the  diluent  before
injection onto the column.
Method
Method  validation  was  performed  according  to  the
parameters established in international guidelines (28-33) for
linearity,  selectivity,  accuracy,  precision,  robustness,
detection limit and quantitation limit.
Linearity
Linearity  was  evaluated  by  regression  analysis.  20 µL of
standard  solutions  (20–200  μL of injected volumes at 275 nm. The samples were prepared in purified water and theg  mL-1  DOX)  were  injected
onto the column in triplicate and the chromatograms were
recorded. The equation of the line was determined by linear
regression analysis by the method of least squares. The peak
height  used  in  determining  the  calibration  curve  was
statistically evaluated by Analysis of Variance (ANOVA).
Wavelength selection, Specificity and Identification of the
peak
The wavelength for determination of peaks was performed
by scanning the standard, vanillin, in the range from 190 nm
to 400 nm. The analysis of the spectrum was used to confirm
the  identity  of  each  compound  of  interest.  Additionally,
scans  from  190  nm  to  400  nm  were  performed  for  the
extract solution from the herbal material, tincture and for the
spiked  extractive  solution  and  tincture  with  the  standard
(vanillin) in order to verify the occurrence of deviation from
the  maximum  wavelength.  Therefore,  the  peak  in  the
samples were identified by comparing their retention time
and area with the standard.
Precision
The precision of the method was performed through three
aspects: intra-assay (repeatability), inter-assay and between
analysts (intermediate precision). Intra-assay precision was
performed by the preparation and analysis of six injections
of DOX at the concentration of 60 μL of injected volumes at 275 nm. The samples were prepared in purified water and theg mL-1, on the same day,
same analyst and in the same working conditions, analyzing
the  RSD  (%)  among  such  determinations.  The  precision
inter-assay  was  performed  by  the  preparation  of  six
injections of DOX in concentration of 60 μL of injected volumes at 275 nm. The samples were prepared in purified water and theg mL-1, in three
different  days,  same  analyst  and  in  the  same  working
conditions,  and about between analysts,  the precision was
performed by the preparation of six injections of DOX in
concentration of 60 μL of injected volumes at 275 nm. The samples were prepared in purified water and theg mL-1, in two different days, different
analysts  and  in  the  same working  conditions.  The  results
were analyzed by RSD (%).
Accuracy
The accuracy of the method was determined by measuring
the reference standard recovery in triplicate at three levels
from 80 to 120% of the method concentration (60 μL of injected volumes at 275 nm. The samples were prepared in purified water and theg mL-1),
according  to  ICH  recommendations  (28).  A  standard
solution containing 200 μL of injected volumes at 275 nm. The samples were prepared in purified water and theg mL-1 of DOX was prepared using
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deionized  Milli  Q  water.  In  volumetric  flasks  of  5  mL,
aliquots of 700, 1000 and 1300 µL of this standard solution
were individually added to 500 µL of sample solutions at
200 μL of injected volumes at 275 nm. The samples were prepared in purified water and theg mL-1. The final concentrations were 48, 60 and 72 μL of injected volumes at 275 nm. The samples were prepared in purified water and theg
mL-1, which correspond to 80, 100 and 120% of the target
concentration,  respectively.  Mean  recovery  and  RSD (%)
were  calculated.  The preparations are  shown in Table 1.  
The  recovery  percentage  (R%)  was  calculated  using  the
Equation 1, which is determined by Association of Official
Analytical Chemists (34).
Table 1. Preparation of the solutions of DOX for the recovery test
of  the  high  performance  liquid  chromatography  method
DOX
sample
(µL)a
DOX
standard
(µL)a
Final theoretical
concentration (μg/g/
mL)b
Level
(%)
R
1 500 700 48 80
R
2 500 1000 60 100
R
3 500 1300 72 120
a -Volumetric flask of 5 mL; b - Concentration levels prepared in
triplicate
Equation  1:  R  %  =  {(Cr  -  Ca)  /  Cp}  x  100
Where:
Cr = Concentration of the standard added sample (μL of injected volumes at 275 nm. The samples were prepared in purified water and theg mL-1)
Ca= Concentration of the sample (μL of injected volumes at 275 nm. The samples were prepared in purified water and theg mL-1)
Cp= Theoretical concentration of standard DOX added (μL of injected volumes at 275 nm. The samples were prepared in purified water and theg 
mL-1)
Selectivity
Selectivity was evaluated by forced degradation procedure
(35). DOX samples solutions were prepared in 0.1 mol L-1
HCl,  0.1  mol  L-1 NaOH,  3%  H2O2  and  H2O  at  a
concentration of 50 μL of injected volumes at 275 nm. The samples were prepared in purified water and theg mL-1.  All solutions were kept in a
water bath at 60 °C. Aliquots of these solutions were taken
at 1, 3 and 6 hours and analyzed immediately by the HPLC
method. Additionally, a solution of DOX was prepared in
water at a concentration of 50 μL of injected volumes at 275 nm. The samples were prepared in purified water and theg mL-1 and submitted to UV
light. Aliquots of this solution were taken at 1, 3 and 6 hours
and analyzed immediately by the HPLC method. An overlap
of  chromatograms  of  DOX  standard  and  sample  was
analyzed  to  prove  the  excipients  do  not  influence  the
quantification.
Robustness
The robustness was evaluated using Youden & Steiner (36)
test. The solutions of of DOX tablets at 60 μL of injected volumes at 275 nm. The samples were prepared in purified water and theg mL-1 were
prepared and analyzed in each conditions. Table 2 shows the
variations that were performed (upper case letters represent
normal working conditions and lower case letters represent
small changes).
Table 2. Combinations analyzed for the robustness evaluation of
the high-performance liquid chromatography method by Youden
and Steiner test.
Experiments
Conditions Normal Changed 1 2 3 4 5 6 7 8
Wavelenght
(nm) 275 276
A A A A A a a a
Ethanol
brand Panreac
® J.T.Baker® B B b B B B b b
% acetic acid 0.5 0.6 C c C C C c C c
Proportion of
etanol 60 61
D D d D D d D D
Flow
(mL/min) 0.8 0.9
E e E E E E e E
Injection
volume (µL) 20 21
F f f F F f f F
Room
temperature
(°C)
25 27 G g g G G G G G
s t u v w x y z
Limits of detection and quantification 
The  limit  of  detection  (LOD)  and  limit  of  quantification
(LOQ) of the method were obtained from Equations 2 and 3:
Equation 2: LOD: 3.3 σ/S
Equation 3: LOQ: 10 σ/S 
Where: 
σ: Standard deviation of the response 
S: Slope of the calibration curve
Results
 
Linearity
A  standard  solution  of  DOX  (200  μL of injected volumes at 275 nm. The samples were prepared in purified water and theg  mL-1)  was
appropriately  diluted  with  the  diluent  solution  to  obtain
solutions  in  the  concentration  range  of  20–200  μL of injected volumes at 275 nm. The samples were prepared in purified water and theg  mL-1
DOX. Twenty microliters of each solution were injected in
triplicate  into  the  column  under  the  previously  described
chromatographic conditions. Figure 2 and Table 3 show the
results.
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Table 3 . Analysis of variance of the values obtained in the analytical curves of DOX using the high-performance liquid chromatography
method
Source of variation
Degree of
freedom
Sum of square Variability tcalculated
tcritical
(0.05)
Between concentrations 5 772369508178 154473901635 311 3.11
Linear regression 1 771944437870 771944437870 1556 4.75
Deviation of linearity 4 425070307 106267576 0.21 3.26
Residue 12 496068171 41339014 - -
Total 17 772865576349 - - -
                                              
Figure 2. Analytical curve of DOX at concentrations of 20, 30 ,40, 60, 80, 100 and 200 μL of injected volumes at 275 nm. The samples were prepared in purified water and theg mL-1 by HPLC method.
Precision
The precision of the method was obtained according to the following criteria: intra-assay (repeatability), inter-assay and between
analysts’ way (intermediate). The Table 4 show the results intra-assay, inter-assay and between two analysts, respectively.
Table 4. Determined values for precision intra-assay, inter-assay and between analysts by high performance liquid chromatography method
Intra-assay Peak height* RSD(%)
1 2 3 4 5 6
Day 1 291020 289664 301938 303978 301876 306768 0.50
Inter-assay Peak heighta* RSD(%)
Day 1 294491
2.35Day 2 304033
Day 3 308362
Between
analysts Peak height*
RSD
(%)
1 2 3 4 5 6
Analyst 1 291020 289664 301938 303978 301876 306768 1.13 Analyst 2 297992 307185 306713 303625 307060 301620
a
Average peak height by six determinations
*Concentration solutions of 60 µg mL-1
Accuracy 
The accuracy of the method was confirmed by determining
the  average  recoveries  from the  samples  by  applying  the
standard addition method. The Table 5 shows the results.
Table 5. Values obtained in the DOX recovery test of the accuracy
parameter by high performance liquid chromatography method
DOX
standard
added (μg/g/
mL)
DOX
standard
found
(μg/g/mL)
Recovery
(%)
Average
Recovery
(%)
RSD
(%)
R1 28 28.25 100.89
R2 40 40.47 101.18 99.85 0.38
R3 52 51.15 98.36
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Robustness  
The  mean  of  variations  in  brand  of  ethanol,  wavelength,
percentage  of  acid  acetic,  proportion  of  ethanol,  room
temperature,  flow  and  injection  volume  to  evaluate  the
robustness parameter was statistically analyzed. The result is
shown in Figure 3.
Figure  3.  Effect  of  the  variations  studied  in  the  parameter
robustness by the Pareto graph.
Selectivity
Selectivity was evaluated by forced degradation procedure
or stress test.  The Figures 4 shows the comparison of the
chromatograms  obtained  for  DOX  sample  in  the  forced
degradation procedure in acidic (A), alkaline (B), oxidative
(C),  neutral  (D)  and  photolytic  media  (E).  The  Figure  5
shows the overlap of chromatograms of DOX standard and
sample.
Limits of detection and quantification
The results of the LOD and LOQ were 1.08 and 3.27 μL of injected volumes at 275 nm. The samples were prepared in purified water and theg mL -
1, respectively.
Discussion
Linearity
The equation of the line, determined by the method of least
squares,  was  y  =  5150.8x  –  7824.5,  with  a  correlation
coefficient (r) greater than 0.9997 and the statistical data did
not  present  significant  linearity  deviation  a 5%  level  of
significance, presenting F calculated (0.21) lower than the F
critical (3.26).
Precision
The  results  were  analyzed  by  RSD  (%).  The  low  RSD
values (0.5,  2.35 and 1.13%) confirm the precision of the
method.
Accuracy 
The mean percentage  recoveries  of the DOX tablets were
found in accordance with the fixed limits of 98.0 to 102.0%
(34).
Robustness  
The robustness  evaluation of the chromatographic method
for  DOX  was  performed  using  the  method  proposed  by
Youden  e  Steiner  (36).  Seven  analytical  parameters  were
selected and small variations were induced in the nominal
conditions of the method. Then, eight runs were performed
aiming to determine the influence of each parameter in the
final result (37).
For the interpretation of the results, must to determine the
influence of variations of each parameter in the final result,
the mean of the four values corresponding to the upper case
letters (normal working) was compared to the mean of the
four values  corresponding  to the lower case letters (small
changes), the final result is the effect value. The effect value
is comparing it with the values obtained experimentally with
the  calculated effect  should be analyzed. In this study the
value  of  calculated  effect  was  9.26.
Thus, the method was robust after the statistical evaluation
of the results, where all the values referring to the calculated
effects were lower, than allowing to occur small variations
that  may  be  recurrent  in  laboratory  routines,  but,  with
reliable results.
Selectivity
The overlay of the peaks obtained from forced degradation
showed that is possible the method was able to identify the
main peak  with degradation.  In  addition,  the method was
selective, since the pharmaceutical tablets excipients do not
influence the quantification of DOX.
Limits of detection and quantification
The values  are low, which indicates  the sensitivity of  the
method and the ability to detect and quantify DOX in tablets
by the proposed method.
Conclusions
An  analytical  HPLC–UV  method  was  developed  and
validated  for  the  quantitative  determination  of  DOX  in
tablets using a mixture of purified water + 0.5 % acetic acid
and  ethanol  (40:60,  v/v).The  results  indicated  that  the
developed HPLC–UV method has been tested positively in
the  following  subjects:  linearity,  precision,  accuracy,
robustness, selectivity, adequate detection and quantification
limits.  Its  advantages  over  other  existing  method  include
lower generation of waste and damages for the environment
and the operator. Finally, it is an alternative method, which
can be ecologically correct  and safe  to be used in routine
analyzes of quality control.
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